Detalhe da pesquisa
1.
The efficacy of natalizumab in patients with multiple sclerosis according to level of disability: results of an observational study.
Mult Scler
; 17(2): 192-7, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21088044
2.
Kinetics and incidence of anti-natalizumab antibodies in multiple sclerosis patients on treatment for 18 months.
Mult Scler
; 17(3): 368-71, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21177326
3.
Validation of the spanish version of the Multiple Sclerosis International Quality of Life (Musiqol) questionnaire.
BMC Neurol
; 11: 127, 2011 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-22013975